Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant avian influenza vaccine and uses thereof

Recombinant avian influenza vaccine and uses thereof

US Patent 8394384 · Granted Mar 12, 2013

Estimated economic value: $65,416,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for producing lysine from microorganism and for constructing microorganis2025
Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses2025
Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses2025
Modified Marek's disease virus, and vaccines made therefrom2025
Modified Marek's disease virus, and vaccines made therefrom2025
Modified Marek's disease virus, and vaccines made therefrom2022
Modified Marek's disease virus, and vaccines made therefrom2022
Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses2022
Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses2022
Recombinant vectors expressing antigens of avian influenza virus and uses thereo2021
Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses2020
Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses2020